Potassium channels in peripheral pain pathways: Expression, function and therapeutic potential

Current Neuropharmacology

Volumn 11, Issue 6, 2013, Pages 621-640

  Du, Xiaona ^a   Gamper, Nikita ^a,b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Dorsal root ganglion; KATP channel; K+ channel; M channel; Nociception; Pain; Two pore K+ channel

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ACRYLAMIDE; ADAMANTANE DERIVATIVE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ANALGESIC AGENT; ANTHRANILIC ACID DERIVATIVE; AUTOANTIBODY; BENZIMIDAZOLE; CALCITONIN GENE RELATED PEPTIDE; CALCIUM ACTIVATED POTASSIUM CHANNEL; DENDROTOXIN; DIAZOXIDE; FAMPRIDINE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.1; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; POTASSIUM CHANNEL; POTASSIUM CHANNEL KCNQ5; POTASSIUM CHANNEL KV1.1; POTASSIUM CHANNEL KV1.2; PYRAZOLO[1,5 A]PYRIMIDINE DERIVATIVE; PYRIDINE DERIVATIVE; SHAB POTASSIUM CHANNEL; SHAKER POTASSIUM CHANNEL; SHAL POTASSIUM CHANNEL; SHAW POTASSIUM CHANNEL; TETRYLAMMONIUM; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; UNINDEXED DRUG; VANILLOID RECEPTOR 1;

ARTICLE; CANCER PAIN; DEREGULATION; DOWN REGULATION; DRUG TARGETING; ELECTROPHYSIOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATORY PAIN; MEMBRANE POTENTIAL; MEMBRANE STEADY POTENTIAL; MIGRAINE; NERVE EXCITABILITY; NEURALGIA; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PAIN; PERIPHERAL NERVE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPINAL GANGLION; UPREGULATION; WESTERN BLOTTING;

EID: 84913549379     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/1570159X113119990042     Document Type: Article

References (220)

1. Raouf, R.; Quick, K.; Wood, J.N. Pain as a channelopathy. J. Clin. Invest., 2010, 120, 3745-3752.
2. Mathie, A. Ion channels as novel therapeutic targets in the treatment of pain. J. Pharm. Pharmacol., 2010, 62, 1089-1095.
3. Peier, A.M.; Moqrich, A.; Hergarden, A.C.; Reeve, A.J.; Andersson, D.A.; Story, G.M.; Earley, T.J.; Dragoni, I.; McIntyre, P.; Bevan, S.; Patapoutian, A. A TRP channel that senses cold stimuli and menthol. Cell, 2002, 108, 705-715.
4. Caterina, M.J.; Schumacher, M.A.; Tominaga, M.; Rosen, T.A.; Levine, J.D.; Julius, D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature, 1997, 389, 816-824.
5. Coste, B.; Mathur, J.; Schmidt, M.; Earley, T.J.; Ranade, S.; Petrus, M.J.; Dubin, A.E.; Patapoutian, A. Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels. Science, 2010, 330, 55-60.
6. Sindrup, S.H.; Graf, A.; Sfikas, N. The NK1-receptor antagonist TKA731 in painful diabetic neuropathy: a randomised, controlled trial. Eur. J. Pain, 2006, 10, 567-571.
7. Sapunar, D.; Ljubkovic, M.; Lirk, P.; McCallum, J.B.; Hogan, Q.H. Distinct membrane effects of spinal nerve ligation on injured and adjacent dorsal root ganglion neurons in rats. Anesthesiology, 2005, 103, 360-376.
8. Linley, J.E.; Pettinger, L.; Huang, D.; Gamper, N. M channel enhancers and physiological M channel block. J. Physiol., 2012, 590, 793-807.
9. Linley, J.E.; Ooi, L.; Pettinger, L.; Kirton, H.; Boyle, J.P.; Peers, C.; Gamper, N. Reactive oxygen species are second messengers of neurokinin signaling in peripheral sensory neurons. Proc. Natl. Acad. Sci. U. S. A., 2012, 109, E1578-E1586.
10. - channels. J. Clin. Invest., 2010, 120, 1240-1252.
11. - cotransport and intracellular chloride regulation in rat primary sensory neurons: thermodynamic and kinetic aspects. J. Neurophysiol., 2008, 100, 169-184.
12. - cotransporter NKCC1 to chloride handling in rat embryonic dorsal root ganglion neurons and motor neurons. FASEB J., 2009, 23, 1168-1176.
13. Gilbert, D.; Franjic-Wurtz, C.; Funk, K.; Gensch, T.; Frings, S.; Mohrlen, F. Differential maturation of chloride homeostasis in primary afferent neurons of the somatosensory system. Int. J. Dev. Neurosci., 2007, 25, 479-489.
14. Funk, K.; Woitecki, A.; Franjic-Wurtz, C.; Gensch, T.; Mohrlen, F.; Frings, S. Modulation of chloride homeostasis by inflammatory mediators in dorsal root ganglion neurons. Mol. Pain., 2008, 4, 32.
15. Bautista, D.M.; Sigal, Y.M.; Milstein, A.D.; Garrison, J.L.; Zorn, J.A.; Tsuruda, P.R.; Nicoll, R.A.; Julius, D. Pungent agents from Szechuan peppers excite sensory neurons by inhibiting two-pore potassium channels. Nat. Neurosci., 2008, 11, 772-779.
16. Linley, J.E.; Rose, K.; Ooi, L.; Gamper, N. Understanding inflammatory pain: ion channels contributing to acute and chronic nociception. Pflugers Arch., 2010, 459, 657-669.
17. Basbaum, A.I.; Bautista, D.M.; Scherrer, G.; Julius, D. Cellular and molecular mechanisms of pain. Cell, 2009, 139, 267-284.
18. Devor, M. Potassium channels moderate ectopic excitability of nerve-end neuromas in rats. Neurosci. Lett., 1983, 40, 181-186.
19. Burchiel, K.J.; Russell, L.C. Effects of potassium channel-blocking agents on spontaneous discharges from neuromas in rats. J. Neurosurg., 1985, 63, 246-249.
20. Klein, C.J.; Lennon, V.A.; Aston, P.A.; McKeon, A.; Pittock, S.J. Chronic pain as a manifestation of potassium channel-complex autoimmunity. Neurology, 2012, 79, 1136-1144.
21. Gutman, G.A.; Chandy, K.G.; Adelman, J.P.; Aiyar, J.; Bayliss, D.A.; Clapham, D.E.; Covarriubias, M.; Desir, G.V.; Furuichi, K.; Ganetzky, B.; Garcia, M.L.; Grissmer, S.; Jan, L.Y.; Karschin, A.; Kim, D.; Kuperschmidt, S.; Kurachi, Y.; Lazdunski, M.; Lesage, F.; Lester, H.A.; McKinnon, D.; Nichols, C.G.; O'Kelly, I.; Robbins, J.; Robertson, G.A.; Rudy, B.; Sanguinetti, M.; Seino, S.; Stuehmer, W.; Tamkun, M.M.; Vandenberg, C.A.; Wei, A.; Wulff, H.; Wymore, R.S. International Union of Pharmacology. XLI. Compendium of Voltage-Gated Ion Channels: Potassium Channels. Pharmacol. Rev., 2003, 55, 583-586.
22. Kostyuk, P.G.; Veselovsky, N.S.; Fedulova, S.A.; Tsyndrenko, A.Y. Ionic currents in the somatic membrane of rat dorsal root ganglion neurons-III. Potassium currents. Neuroscience, 1981, 6, 2439-2444.
23. Stansfeld, C.E.; Marsh, S.J.; Parcej, D.N.; Dolly, J.O.; Brown, D.A. Mast cell degranulating peptide and dendrotoxin selectively inhibit a fast-activating potassium current and bind to common neuronal proteins. Neuroscience, 1987, 23, 893-902.
24. McFarlane, S.; Cooper, E. Kinetics and voltage dependence of A-type currents on neonatal rat sensory neurons. J. Neurophysiol., 1991, 66, 1380-1391.
25. + currents in cultured sensory neurones from neonatal rats. Br. J. Pharmacol., 1994, 113, 959-967.
26. + currents in adult rat sensory neurons. J. Neurophysiol., 1996, 75, 2629-2646.
27. + currents in dorsal root ganglion neurones innervating the rat urinary bladder. J. Physiol., 1996, 494, 1-16.
28. Yang, E.K.; Takimoto, K.; Hayashi, Y.; de Groat, W.C.; Yoshimura, N. Altered expression of potassium channel subunit mRNA and alpha-dendrotoxin sensitivity of potassium currents in rat dorsal root ganglion neurons after axotomy. Neuroscience, 2004, 123, 867-874.
29. Akins, P.T.; McCleskey, E.W. Characterization of potassium currents in adult rat sensory neurons and modulation by opioids and cyclic AMP. Neuroscience, 1993, 56, 759-769.
30. Everill, B.; Rizzo, M.A.; Kocsis, J.D. Morphologically identified cutaneous afferent DRG neurons express three different potassium currents in varying proportions. J. Neurophysiol., 1998, 79, 1814-1824.
31. Rasband, M.N.; Park, E.W.; Vanderah, T.W.; Lai, J.; Porreca, F.; Trimmer, J.S. Distinct potassium channels on pain-sensing neurons. Proc. Natl. Acad. Sci. U. S. A., 2001, 98, 13373-13378.
32. Kim, D.S.; Choi, J.O.; Rim, H.D.; Cho, H.J. Downregulation of voltage-gated potassium channel alpha gene expression in dorsal root ganglia following chronic constriction injury of the rat sciatic nerve. Brain Res. Mol. Brain Res., 2002, 105, 146-152.
33. + currents influence firing properties of isolectin B4-positive but not isolectin B4-negative primary sensory neurons. J. Neurophysiol., 2005, 93, 3401-3409.
34. + channels. Ann. N. Y. Acad. Sci., 1999, 868, 233-285.
35. + current in cultured small mouse DRG neurons. Am. J. Physiol. Cell. Physiol., 2009, 296, C1271-1278.
36. Tsantoulas, C.; Zhu, L.; Shaifta, Y.; Grist, J.; Ward, J.P.; Raouf, R.; Michael, G.J.; McMahon, S.B. Sensory Neuron Downregulation of the Kv9.1 Potassium Channel Subunit Mediates Neuropathic Pain following Nerve Injury. J. Neurosci., 2012, 32, 17502-17513.
37. Johnston, J.; Forsythe, I.D.; Kopp-Scheinpflug, C. Going native: voltage-gated potassium channels controlling neuronal excitability. J. Physiol., 2010, 588, 3187-3200.
38. Chien, L.Y.; Cheng, J.K.; Chu, D.; Cheng, C.F.; Tsaur, M.L. Reduced expression of A-type potassium channels in primary sensory neurons induces mechanical hypersensitivity. J. Neurosci., 2007, 27, 9855-9865.
39. Phuket, T.R.; Covarrubias, M. Kv4 Channels Underlie the Subthreshold-Operating A-type K-current in Nociceptive Dorsal Root Ganglion Neurons. Front. Mol. Neurosci., 2009, 2, 3.
40. Matsuyoshi, H.; Takimoto, K.; Yunoki, T.; Erickson, V.L.; Tyagi, P.; Hirao, Y.; Wanaka, A.; Yoshimura, N. Distinct cellular distributions of Kv4 pore-forming and auxiliary subunits in rat dorsal root ganglion neurons. Life Sci., 2012, 91, 258-263.
41. Huang, H.; Trussell, L.O. KCNQ5 channels control resting properties and release probability of a synapse. Nat. Neurosci., 2011, 14, 840-847.
42. Delmas, P.; Brown, D.A. Pathways modulating neural KCNQ/M (Kv7) potassium channels. Nat. Rev. Neurosci., 2005, 6, 850-862.
43. Shapiro, M.S., Gamper, N. Regulation of Neuronal Ion Channels by G-Protein-Coupled Receptors in Sympathetic Neurons. In: Gribkoff, V.K., Kaczmarek, L.K. Ed, Structure, Function and Modulation of Neuronal Voltage-Gated Ion Channels. Hoboken, New Jersey, Wiley. 2009, 291-316.
44. Passmore, G.M.; Selyanko, A.A.; Mistry, M.; Al-Qatari, M.; Marsh, S.J.; Matthews, E.A.; Dickenson, A.H.; Brown, T.A.; Burbidge, S.A.; Main, M.; Brown, D.A. KCNQ/M currents in sensory neurons: significance for pain therapy. J. Neurosci., 2003, 23, 7227-7236.
45. Rose, K.; Ooi, L.; Dalle, C.; Robertson, B.; Wood, I.C.; Gamper, N. Transcriptional repression of the M channel subunit Kv7.2 in chronic nerve injury. Pain, 2011, 152, 742-754.
46. King, C.H.; Scherer, S.S. Kv7.5 is the primary Kv7 subunit expressed in C-fibers. J. Comp. Neurol., 2012, 520, 1940-1950.
47. Zheng, Q.; Fang, D.; Liu, M.; Cai, J.; Wan, Y.; Han, J.S.; Xing, G.G. Suppression of KCNQ/M (Kv7) potassium channels in dorsal root ganglion neurons contributes to the development of bone cancer pain in a rat model. Pain, 2013, 154, 434-448.
48. Passmore, G.M.; Reilly, J.M.; Thakur, M.; Keasberry, V.N.; Marsh, S.J.; Dickenson, A.H.; Brown, D.A. Functional significance of M-type potassium channels in nociceptive cutaneous sensory endings. Front. Mol. Neurosci., 2012, 5, 63.
49. + channel. J. Neurosci., 2004, 24, 1236-1244.
50. Roza, C.; Castillejo, S.; Lopez-Garcia, J.A. Accumulation of Kv7.2 channels in putative ectopic transduction zones of mice nerve-end neuromas. Mol. Pain, 2011, 7, 58.
51. Rivera-Arconada, I.; Lopez-Garcia, J.A. Retigabine-induced population primary afferent hyperpolarisation in vitro. Neuropharmacology, 2006, 51, 756-763.
52. Linley, J.E.; Rose, K.; Patil, M.; Robertson, B.; Akopian, A.N.; Gamper, N. Inhibition of M current in sensory neurons by exogenous proteases: a signaling pathway mediating inflammatory nociception. J. Neurosci., 2008, 28, 11240-11249.
53. Blackburn-Munro, G.; Jensen, B.S. The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain. Eur. J. Pharmacol., 2003, 460, 109-116.
54. Hirano, K.; Kuratani, K.; Fujiyoshi, M.; Tashiro, N.; Hayashi, E.; Kinoshita, M. Kv7.2-7.5 voltage-gated potassium channel (KCNQ2-5) opener, retigabine, reduces capsaicin-induced visceral pain in mice. Neurosci. Lett., 2007, 413, 159-162.
55. Lang, P.M.; Fleckenstein, J.; Passmore, G.M.; Brown, D.A.; Grafe, P. Retigabine reduces the excitability of unmyelinated peripheral human axons. Neuropharmacology, 2008, 54, 1271-1278.
56. Roza, C.; Lopez-Garcia, J.A. Retigabine, the specific KCNQ channel opener, blocks ectopic discharges in axotomized sensory fibres. Pain, 2008, 138, 537-545.
57. Wladyka, C.L.; Feng, B.; Glazebrook, P.A.; Schild, J.H.; Kunze, D.L. The KCNQ/M-current modulates arterial baroreceptor function at the sensory terminal in rats. J. Physiol., 2008, 586, 795-802.
58. Plant, L.D. A Role for K2P Channels in the Operation of Somatosensory Nociceptors. Front. Mol. Neurosci., 2012, 5, 21.
59. Lopes, C.M.; Zilberberg, N.; Goldstein, S.A. Block of Kcnk3 by protons. Evidence that 2-P-domain potassium channel subunits function as homodimers. J. Biol. Chem., 2001, 276, 24449-24452.
60. Kollewe, A.; Lau, A.Y.; Sullivan, A.; Roux, B.; Goldstein, S.A. A structural model for K2P potassium channels based on 23 pairs of interacting sites and continuum electrostatics. J. Gen. Physiol., 2009, 134, 53-68.
61. Honore, E. The neuronal background K2P channels: focus on TREK-1. Nat. Rev. Neurosci., 2007, 8, 251-261.
62. Hodgkin, A.L.; Huxley, A.F. The components of membrane conductance in the giant axon of Loligo. J. Physiol., 1952, 116, 473-496.
63. Talley, E.M.; Solorzano, G.; Lei, Q.; Kim, D.; Bayliss, D.A. Cns distribution of members of the two-pore-domain (KCNK) potassium channel family. J. Neurosci., 2001, 21, 7491-7505.
64. + channel mRNAs in dorsal root ganglia: relation to inflammation and spontaneous pain behaviour. Mol. Cell. Neurosci., 2012, 49, 375-386.
65. + channels in dorsal root ganglion neurons. Am. J. Physiol. Cell.Physiol., 2006, 291, C138-146.
66. + channel. EMBO J., 1998, 17, 4283-4290.
67. Maingret, F.; Patel, A.J.; Lesage, F.; Lazdunski, M.; Honore, E. Mechano-or acid stimulation, two interactive modes of activation of the TREK-1 potassium channel. J. Biol. Chem., 1999, 274, 26691-26696.
68. + channel. EMBO J., 2000, 19, 2483-2491.
69. + channels TREK-2 and TRAAK. J. Physiol., 2005, 564, 103-116.
70. Lopes, C.M.; Gallagher, P.G.; Buck, M.E.; Butler, M.H.; Goldstein, S.A. Proton block and voltage gating are potassium-dependent in the cardiac leak channel Kcnk3. J. Biol. Chem., 2000, 275, 16969-16978.
71. + channel family. J. Biol. Chem., 2000, 275, 9340-9347.
72. Hibino, H.; Inanobe, A.; Furutani, K.; Murakami, S.; Findlay, I.; Kurachi, Y. Inwardly rectifying potassium channels: their structure, function, and physiological roles. Physiol. Rev., 2010, 90, 291-366.
73. ATP channels. J. Mol. Cell. Cardiol., 2005, 38, 945-949.
74. ATP channel subunits in rat dorsal root ganglia: alterations by painful axotomy. Mol. Pain, 2010, 6, 6.
75. Du, X.; Wang, C.; Zhang, H. Activation of ATP-sensitive potassium channels antagonize nociceptive behavior and hyperexcitability of DRG neurons from rats. Mol. Pain., 2011, 7, 35.
76. Salkoff, L.; Butler, A.; Ferreira, G.; Santi, C.; Wei, A. High-conductance potassium channels of the SLO family. Nat. Rev. Neurosci., 2006, 7, 921-931.
77. + channels in small neurones of rat dorsal root ganglion studied in a thin slice preparation. J. Physiol., 1998, 513, 55-69.
78. + channels in rat dorsal root ganglion neurons. J. Cell. Physiol., 2007, 212, 348-357.
79. Na channels produces dorsal root ganglion neuron hyperexcitability. J. Neurosci., 2010, 30, 14165-14172.
80. Tamsett, T.J.; Picchione, K.E.; Bhattacharjee, A. NAD+ activates KNa channels in dorsal root ganglion neurons. J. Neurosci., 2009, 29, 5127-5134.
81. Na channels are required for the depolarizing afterpotential of acutely isolated, medium diameter rat dorsal root ganglion neurons. Acta Pharmacol. Sin., 2008, 29, 899-905.
82. Nuwer, M.O.; Picchione, K.E.; Bhattacharjee, A. cAMP-dependent kinase does not modulate the Slack sodium-activated potassium channel. Neuropharmacology, 2009, 57, 219-226.
83. International Association for the Study og Pain. 2012 http://www. iasp-pain.org/Content/NavigationMenu/GeneralResourceLinks/Pain Definitions/default.htm
84. Campbell, J.N.; Meyer, R.A. Mechanisms of neuropathic pain. Neuron, 2006, 52, 77-92.
85. O'Connor, A.B.; Dworkin, R.H. Treatment of neuropathic pain: an overview of recent guidelines. Am. J. Med., 2009, 122, S22-32.
86. Devor, M. Response of nerves to Injury in relation to neuropathic pain. In: McMahon, S.B., Koltzenburg, M. Ed, Wall and Melzack's Textbook of Pain, Elsevier Churchill Livingstone. 2006, 905-927.
87. Fawcett, J.W.; Keynes, R.J. Peripheral nerve regeneration. Annu. Rev. Neurosci., 1990, 13, 43-60.
88. Govrin-Lippmann, R.; Devor, M. Ongoing activity in severed nerves: source and variation with time. Brain Res., 1978, 159, 406-410.
89. Wall, P.D.; Devor, M. Sensory afferent impulses originate from dorsal root ganglia as well as from the periphery in normal and nerve injured rats. Pain, 1983, 17, 321-339.
90. Amir, R.; Devor, M. Spike-evoked suppression and burst patterning in dorsal root ganglion neurons of the rat. J. Physiol., 1997, 501, 183-196.
91. Liu, C.N.; Wall, P.D.; Ben-Dor, E.; Michaelis, M.; Amir, R.; Devor, M. Tactile allodynia in the absence of C-fiber activation: altered firing properties of DRG neurons following spinal nerve injury. Pain, 2000, 85, 503-521.
92. Ren, K.; Dubner, R. Inflammatory Models of Pain and Hyperalgesia. Ilar J., 1999, 40, 111-118.
93. Chung, K.; Lee, B.H.; Yoon, Y.W.; Chung, J.M. Sympathetic sprouting in the dorsal root ganglia of the injured peripheral nerve in a rat neuropathic pain model. J. Comp. Neurol., 1996, 376, 241-252.
94. McLachlan, E.M.; Janig, W.; Devor, M.; Michaelis, M. Peripheral nerve injury triggers noradrenergic sprouting within dorsal root ganglia. Nature, 1993, 363, 543-546.
95. Xiao, H.S.; Huang, Q.H.; Zhang, F.X.; Bao, L.; Lu, Y.J.; Guo, C.; Yang, L.; Huang, W.J.; Fu, G.; Xu, S.H.; Cheng, X.P.; Yan, Q.; Zhu, Z.D.; Zhang, X.; Chen, Z.; Han, Z.G.; Zhang, X. Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain. Proc. Natl. Acad. Sci. U. S. A., 2002, 99, 8360-8365.
96. Everill, B.; Kocsis, J.D. Reduction in potassium currents in identified cutaneous afferent dorsal root ganglion neurons after axotomy. J. Neurophysiol., 1999, 82, 700-708.
97. + channel currents of rat dorsal root ganglion neurons. J. Neurophysiol., 2001, 85, 644-658.
98. Jaggi, A.S.; Jain, V.; Singh, N. Animal models of neuropathic pain. Fundam. Clin. Pharmacol., 2011, 25, 1-28.
99. Hansen, H.H.; Ebbesen, C.; Mathiesen, C.; Weikop, P.; Ronn, L.C.; Waroux, O.; Scuvee-Moreau, J.; Seutin, V.; Mikkelsen, J.D. The KCNQ channel opener retigabine inhibits the activity of mesencephalic dopaminergic systems of the rat. J. Pharmacol. Exp. Ther., 2006, 318, 1006-1019.
100. Mucha, M.; Ooi, L.; Linley, J.E.; Mordaka, P.; Dalle, C.; Robertson, B.; Gamper, N.; Wood, I.C. Transcriptional control of KCNQ channel genes and the regulation of neuronal excitability. J. Neurosci., 2010, 30, 13235-13245.
101. Iannotti, F.A.; Barrese, V.; Formisano, L.; Miceli, F.; Taglialatela, M. Specification of Skeletal Muscle Differentiation by Repressor Element-1 Silencing Transcription Factor (REST)-Regulated Kv7.4 Potassium Channels. Mol. Biol. Cell., 2012, 24 (3), 274-84.
102. Uchida, H.; Ma, L.; Ueda, H. Epigenetic gene silencing underlies C-fiber dysfunctions in neuropathic pain. J. Neurosci., 2010, 30, 4806-4814.
103. Ooi, L.; Wood, I.C. Chromatin crosstalk in development and disease: lessons from REST. Nat. Rev. Genet., 2007, 8, 544-554.
104. + channels by AKAP79/150-mediated NFAT actions. Neuron, 2012, 76, 1133-1146.
105. Cai, Y.Q.; Chen, S.R.; Pan, H.L. Upregulation of nuclear factor of activated T-cells by nerve injury contributes to development of neuropathic pain. J. Pharmacol. Exp. Ther., 2013, 345, 161-168.
106. Uchida, H.; Sasaki, K.; Ma, L.; Ueda, H. Neuron-restrictive silencer factor causes epigenetic silencing of Kv4.3 gene after peripheral nerve injury. Neuroscience, 2010, 166, 1-4.
107. + channel activity in primary sensory neurons in painful diabetic neuropathy: role of brain-derived neurotrophic factor. J. Neurochem., 2010, 114, 1460-1475.
108. Qian, A.H.; Liu, X.Q.; Yao, W.Y.; Wang, H.Y.; Sun, J.; Zhou, L.; Yuan, Y.Z. Voltage-gated potassium channels in IB4-positive colonic sensory neurons mediate visceral hypersensitivity in the rat. Am. J. Gastroenterol, 2009, 104, 2014-2027.
109. Ishikawa, K.; Tanaka, M.; Black, J.A.; Waxman, S.G. Changes in expression of voltage-gated potassium channels in dorsal root ganglion neurons following axotomy. Muscle Nerve, 1999, 22, 502-507.
110. Kajander, K.C.; Bennett, G.J. Onset of a painful peripheral neuropathy in rat: a partial and differential deafferentation and spontaneous discharge in A beta and A delta primary afferent neurons. J. Neurophysiol., 1992, 68, 734-744.
111. Boucher, T.J.; Okuse, K.; Bennett, D.L.; Munson, J.B.; Wood, J.N.; McMahon, S.B. Potent analgesic effects of GDNF in neuropathic pain states. Science, 2000, 290, 124-127.
112. Bocksteins, E.; Snyders, D.J. Electrically silent Kv subunits: their molecular and functional characteristics. Physiology (Bethesda), 2012, 27, 73-84.
113. Richardson, F.C.; Kaczmarek, L.K. Modification of delayed rectifier potassium currents by the Kv9.1 potassium channel subunit. Hear. Res., 2000, 147, 21-30.
114. Serhan, C.N.; Savill, J. Resolution of inflammation: the beginning programs the end. Nat. Immunol., 2005, 6, 1191-1197.
115. Ferrero-Miliani, L.; Nielsen, O.H.; Andersen, P.S.; Girardin, S.E. Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation. Clin. Exp. Immunol., 2007, 147, 227-235.
116. Keele, C.A. The chemistry of pain production. Proc. R. Soc. Med., 1967, 60, 419-422.
117. McMahon, S.B., Bennet, D.L.H., Bevan, S. Inflammatory mediators and modulators. In: McMahon, S.B., Koltzenburg, M. Ed, Wall and Melzack's textbook of pain. Edinburgh, Elsevier Churchill Livingstone. 2006, 49-72.
118. Petho, G.; Reeh, P.W. Sensory and signaling mechanisms of bradykinin, eicosanoids, platelet-activating factor, and nitric oxide in peripheral nociceptors. Physiol. Rev., 2012, 92, 1699-1775.
119. Miyamoto, T.; Dubin, A.E.; Petrus, M.J.; Patapoutian, A. TRPV1 and TRPA1 mediate peripheral nitric oxide-induced nociception in mice. PLoS One, 2009, 4, e7596.
120. Nilius, B.; Voets, T.; Peters, J. TRP channels in disease. Sci. STKE, 2005, 2005, re8.
121. Ma, W.; Quirion, R. Inflammatory mediators modulating the transient receptor potential vanilloid 1 receptor: therapeutic targets to treat inflammatory and neuropathic pain. Expert Opin. Ther. Targets, 2007, 11, 307-320.
122. Vay, L.; Gu, C.; McNaughton, P.A. The thermo-TRP ion channel family: properties and therapeutic implications. Br. J. Pharmacol., 2012, 165, 787-801.
123. Hattori, T.; Chen, J.; Harding, A.M.; Price, M.P.; Lu, Y.; Abboud, F.M.; Benson, C.J. ASIC2a and ASIC3 heteromultimerize to form pH-sensitive channels in mouse cardiac dorsal root ganglia neurons. Circ. Res., 2009, 105, 279-286.
124. Yiangou, Y.; Facer, P.; Smith, J.A.; Sangameswaran, L.; Eglen, R.; Birch, R.; Knowles, C.; Williams, N.; Anand, P. Increased acid-sensing ion channel ASIC-3 in inflamed human intestine. Eur. J. Gastroenterol. Hepatol., 2001, 13, 891-896.
125. Deval, E.; Noel, J.; Lay, N.; Alloui, A.; Diochot, S.; Friend, V.; Jodar, M.; Lazdunski, M.; Lingueglia, E. ASIC3, a sensor of acidic and primary inflammatory pain. EMBO J., 2008, 27, 3047-3055.
126. Rocha-Gonzalez, H.I.; Herrejon-Abreu, E.B.; Lopez-Santillan, F.J.; Garcia-Lopez, B.E.; Murbartian, J.; Granados-Soto, V. Acid increases inflammatory pain in rats: effect of local peripheral ASICs inhibitors. Eur. J. Pharmacol., 2009, 603, 56-61.
127. Dai, Y.; Fukuoka, T.; Wang, H.; Yamanaka, H.; Obata, K.; Tokunaga, A.; Noguchi, K. Contribution of sensitized P2X receptors in inflamed tissue to the mechanical hypersensitivity revealed by phosphorylated ERK in DRG neurons. Pain, 2004, 108, 258-266.
128. Oliveira, M.C.; Pelegrini-da-Silva, A.; Tambeli, C.H.; Parada, C.A. Peripheral mechanisms underlying the essential role of P2X3,2/3 receptors in the development of inflammatory hyperalgesia. Pain, 2009, 141, 127-134.
129. Hamilton, S.G.; Wade, A.; McMahon, S.B. The effects of inflammation and inflammatory mediators on nociceptive behaviour induced by ATP analogues in the rat. Br. J. Pharmacol., 1999, 126, 326-332.
130. Tsuda, M.; Koizumi, S.; Kita, A.; Shigemoto, Y.; Ueno, S.; Inoue, K. Mechanical allodynia caused by intraplantar injection of P2X receptor agonist in rats: involvement of heteromeric P2X2/3 receptor signaling in capsaicin-insensitive primary afferent neurons. J. Neurosci., 2000, 20, RC90.
131. Hamilton, S.G.; McMahon, S.B.; Lewin, G.R. Selective activation of nociceptors by P2X receptor agonists in normal and inflamed rat skin. J. Physiol., 2001, 534, 437-445.
132. Cockayne, D.A.; Dunn, P.M.; Zhong, Y.; Rong, W.; Hamilton, S.G.; Knight, G.E.; Ruan, H.Z.; Ma, B.; Yip, P.; Nunn, P.; McMahon, S.B.; Burnstock, G.; Ford, A.P. P2X2 knockout mice and P2X2/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP. J. Physiol., 2005, 567, 621-639.
133. Maingret, F.; Coste, B.; Padilla, F.; Clerc, N.; Crest, M.; Korogod, S.M.; Delmas, P. Inflammatory mediators increase Nav1.9 current and excitability in nociceptors through a coincident detection mechanism. J. Gen. Physiol., 2008, 131, 211-225.
134. Binshtok, A.M.; Wang, H.; Zimmermann, K.; Amaya, F.; Vardeh, D.; Shi, L.; Brenner, G.J.; Ji, R.R.; Bean, B.P.; Woolf, C.J.; Samad, T.A. Nociceptors are interleukin-1beta sensors. J. Neurosci., 2008, 28, 14062-14073.
135. Jin, X.; Gereau, R.W.t. Acute p38-mediated modulation of tetrodotoxin-resistant sodium channels in mouse sensory neurons by tumor necrosis factor-alpha. J. Neurosci., 2006, 26, 246-255.
136. v1.8 current by neurokinin-1 receptor activation in rat dorsal root ganglion neurons. Mol. Pain, 2009, 5, 33.
137. v1.8 peripheral nerve sodium channels by protein kinase A and protein kinase C. J. Neurophysiol., 2004, 91, 1556-1569.
138. + current in a vertebrate neurone. Nature, 1980, 283, 673-676.
139. 2 hydrolysis: significance for receptor-mediated inhibition. J. Physiol., 2007, 582, 917-925.
140. Hernandez, C.C.; Zaika, O.; Tolstykh, G.P.; Shapiro, M.S. Regulation of neural KCNQ channels: signalling pathways, structural motifs and functional implications. J. Physiol., 2008, 586, 1811-1821.
141. Gamper, N.; Rohacs, T. Phosphoinositide sensitivity of ion channels, a functional perspective. Subcell. Biochem., 2012, 59, 289-333.
142. Suh, B.; Hille, B. Recovery from muscarinic modulation of M current channels requires phosphatidylinositol 4,5-bisphosphate synthesis. Neuron, 2002, 35, 507-520.
143. 2 activates KCNQ channels, and its hydrolysis underlies receptor-mediated inhibition of M currents. Neuron, 2003, 37, 963-975.
144. + channel open probability by phosphatidylinositol (4,5)-bisphosphate. J. Neurosci., 2005, 25, 9825-9835.
145. 2+ stores in rat sympathetic neurons. Proc. Natl. Acad. Sc.i U. S. A., 1998, 95, 7151-7156.
146. Gamper, N.; Shapiro, M.S. Calmodulin mediates Ca2+-dependent modulation of M-type K+ channels. J. Gen. Physiol., 2003, 122, 17-31.
147. Selyanko, A.A.; Brown, D.A. Intracellular calcium directly inhibits potassium M channels in excised membrane patches from rat sympathetic neurons. Neuron, 1996, 16, 151-162.
148. 2+/calmodulin. Mol. Biol. Cell., 2005, 16, 3538-3551.
149. Hoshi, N.; Zhang, J.S.; Omaki, M.; Takeuchi, T.; Yokoyama, S.; Wanaverbecq, N.; Langeberg, L.K.; Yoneda, Y.; Scott, J.D.; Brown, D.A.; Higashida, H. AKAP150 signaling complex promotes suppression of the M-current by muscarinic agonists. Nat. Neurosci., 2003, 6, 564-571.
150. Zhang, J.; Bal, M.; Bierbower, S.; Zaika, O.; Shapiro, M.S. AKAP79/150 signal complexes in G-protein modulation of neuronal ion channels. J. Neurosci., 2011, 31, 7199-7211.
151. Couture, R.; Harrisson, M.; Vianna, R.M.; Cloutier, F. Kinin receptors in pain and inflammation. Eur. J. Pharmacol., 2001, 429, 161-176.
152. Kuhn, B.; Schmid, A.; Harteneck, C.; Gudermann, T.; Schultz, G. G proteins of the Gq family couple the H2 histamine receptor to phospholipase C. Mol. Endocrinol., 1996, 10, 1697-1707.
153. Bushell, T.J.; Plevin, R.; Cobb, S.; Irving, A.J. Characterization of proteinase-activated receptor 2 signalling and expression in rat hippocampal neurons and astrocytes. Neuropharmacology, 2006, 50, 714-725.
154. Breyer, M.D.; Jacobson, H.R.; Breyer, R.M. Functional and molecular aspects of renal prostaglandin receptors. J. Am. Soc. Nephrol., 1996, 7, 8-17.
155. Chen, C.C.; Chen, W.C. P2Y receptor linked to phospholipase C: stimulation of neuro 2A cells by UTP and ATP and possible regulation by protein kinase C subtype epsilon. J. Neurochem., 1997, 69, 1409-1416.
156. Dray, A.; Perkins, M. Bradykinin and inflammatory pain. Trends Neurosci., 1993, 16, 99-104.
157. Crozier, R.A.; Ajit, S.K.; Kaftan, E.J.; Pausch, M.H. MrgD activation inhibits KCNQ/M-currents and contributes to enhanced neuronal excitability. J. Neurosci., 2007, 27, 4492-4496.
158. + channels mediates reciprocal channel modulation by nitric oxide and reactive oxygen species. J Neurosci, 2013, 33, 6041-6046.
159. + channels in a rat nociceptive cell. Neuroscience, 2004, 129, 209-224.
160. + channels in capsaicin sensitive and insensitive cells of rat dorsal root ganglia. Neuroscience, 2006, 141, 955-963.
161. Wemmie, J.A.; Price, M.P.; Welsh, M.J. Acid-sensing ion channels: advances, questions and therapeutic opportunities. Trends Neurosci., 2006, 29, 578-586.
162. + channels. J. Physiol., 2005, 564, 117-129.
163. + channels into open leak channels. EMBO J., 2006, 25, 5864-5872.
164. + channels. EMBO J., 2003, 22, 5403-5411.
165. Chen, X.; Talley, E.M.; Patel, N.; Gomis, A.; McIntire, W.E.; Dong, B.; Viana, F.; Garrison, J.C.; Bayliss, D.A. Inhibition of a background potassium channel by Gq protein alpha-subunits. Proc. Natl. Acad. Sci. U. S. A., 2006, 103, 3422-3427.
166. + channel. EMBO J., 1996, 15, 6854-6862.
167. Woolf, C.J.; Costigan, M. Transcriptional and posttranslational plasticity and the generation of inflammatory pain. Proc. Natl. Acad. Sci. U. S. A., 1999, 96, 7723-7730.
168. Zhu, Y.; Colak, T.; Shenoy, M.; Liu, L.; Mehta, K.; Pai, R.; Zou, B.; Xie, X.S.; Pasricha, P.J. Transforming growth factor beta induces sensory neuronal hyperexcitability, and contributes to pancreatic pain and hyperalgesia in rats with chronic pancreatitis. Mol. Pain, 2012, 8, 65.
169. Prinsloo, S.; Gabel, S.; Lyle, R.; Cohen, L. Neuromodulation of Cancer Pain. Integrative Cancer Ther., 2013, (in press).
170. + channels in primary sensory neurons for bone cancer pain in a rat model. Pain, 2012, 153, 562-574.
171. Gribkoff, V.K. The therapeutic potential of neuronal Kv7 (KCNQ) channel modulators: an update. Expert Opin. Ther. Targets, 2008, 12, 565-581.
172. Wang, H.S.; Pan, Z.; Shi, W.; Brown, B.S.; Wymore, R.S.; Cohen, I.S.; Dixon, J.E.; McKinnon, D. KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science, 1998, 282, 1890-1893.
173. Biervert, C.; Schroeder, B.C.; Kubisch, C.; Berkovic, S.F.; Propping, P.; Jentsch, T.J.; Steinlein, O.K. A potassium channel mutation in neonatal human epilepsy. Science, 1998, 279, 403-406.
174. Charlier, C.; Singh, N.A.; Ryan, S.G.; Lewis, T.B.; Reus, B.E.; Leach, R.J.; Leppert, M. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat. Genet., 1998, 18, 53-55.
175. Singh, N.A.; Charlier, C.; Stauffer, D.; DuPont, B.R.; Leach, R.J.; Melis, R.; Ronen, G.M.; Bjerre, I.; Quattlebaum, T.; Murphy, J.V.; McHarg, M.L.; Gagnon, D.; Rosales, T.O.; Peiffer, A.; Anderson, V.E.; Leppert, M. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat. Genet., 1998, 18, 25-29.
176. Yang, W.P.; Levesque, P.C.; Little, W.A.; Conder, M.L.; Ramakrishnan, P.; Neubauer, M.G.; Blanar, M.A. Functional expression of two KvLQT1-related potassium channels responsible for an inherited idiopathic epilepsy. J. Biol. Chem., 1998, 273, 19419-19423.
177. Rivera-Arconada, I.; Roza, C.; Lopez-Garcia, J.A. Enhancing m currents: a way out for neuropathic pain? Front. Mol. Neurosci., 2009, 2, 10.
178. Stafstrom, C.E.; Grippon, S.; Kirkpatrick, P. Ezogabine (retigabine). Nat. Rev. Drug Discov., 2011, 10, 729-730.
179. Passmore, G.; Delmas, P. Does cure for pain REST on Kv7 channels? Pain, 2011, 152, 709-710.
180. Mastronardi, P.; D'Onofrio, M.; Scanni, E.; Pinto, M.; Frontespezi, S.; Ceccarelli, M.G.; Bianchi, F.; Mazzarella, B. Analgesic activity of flupirtine maleate: a controlled double-blind study with diclofenac sodium in orthopaedics. J. Int. Med. Res., 1988, 16, 338-348.
181. Devulder, J. Flupirtine in pain management: pharmacological properties and clinical use. CNS Drugs, 2010, 24, 867-881.
182. Peretz, A.; Degani, N.; Nachman, R.; Uziyel, Y.; Gibor, G.; Shabat, D.; Attali, B. Meclofenamic acid and diclofenac, novel templates of KCNQ2/Q3 potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties. Mol. Pharmacol., 2005, 67, 1053-1066.
183. Brueggemann, L.I.; Mackie, A.R.; Mani, B.K.; Cribbs, L.L.; Byron, K.L. Differential effects of selective cyclooxygenase-2 inhibitors on vascular smooth muscle ion channels may account for differences in cardiovascular risk profiles. Mol. Pharmacol., 2009, 76, 1053-1061.
184. Du, X.N.; Zhang, X.; Qi, J.L.; An, H.L.; Li, J.W.; Wan, Y.M.; Fu, Y.; Gao, H.X.; Gao, Z.B.; Zhan, Y.; Zhang, H.L. Characteristics and molecular basis of celecoxib modulation on Kv7 potassium channels. Br. J. Pharmacol., 2011, 164, 1722-1737.
185. Fritch, P.C.; McNaughton-Smith, G.; Amato, G.S.; Burns, J.F.; Eargle, C.W.; Roeloffs, R.; Harrison, W.; Jones, L.; Wickenden, A.D. Novel KCNQ2/Q3 Agonists as Potential Therapeutics for Epilepsy and Neuropathic Pain. J. Med. Chem., 2009, 53, 887-896.
186. Tatulian, L.; Delmas, P.; Abogadie, F.C.; Brown, D.A. Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine. J. Neurosci., 2001, 21, 5535-5545.
187. Wickenden, A.D.; Yu, W.; Zou, A.; Jegla, T.; Wagoner, P.K. Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels. Mol. Pharmacol., 2000, 58, 591-600.
188. Zhang, D.; Thimmapaya, R.; Zhang, X.F.; Anderson, D.J.; Baranowski, J.L.; Scanio, M.; Perez-Medrano, A.; Peddi, S.; Wang, Z.; Patel, J.R.; DeGoey, D.A.; Gopalakrishnan, M.; Honore, P.; Yao, B.B.; Surowy, C.S. KCNQ2/3 openers show differential selectivity and site of action across multiple KCNQ channels. J. Neurosci. Methods, 2011, 200, 54-62.
189. Hewawasam, P.; Fan, W.; Cook, D.A.; Newberry, K.S.; Boissard, C.G.; Gribkoff, V.K.; Starrett, J.; Lodge, N.J. 4-Aryl-3-(mercapto)quinolin-2-ones: novel maxi-K channel opening relaxants of corporal smooth muscle. Bioorg. Med. Chem. Lett., 2004, 14, 4479-4482.
190. L'Heureux, A.; Martel, A.; He, H.; Chen, J.; Sun, L.Q.; Starrett, J.E.; Natale, J.; Dworetzky, S.I.; Knox, R.J.; Harden, D.G.; Weaver, D.; Thompson, M.W.; Wu, Y.J. (S,E)-N-[1-(3-heteroarylphenyl)ethyl]-3-(2-fluorophenyl)acrylamides: synthesis and KCNQ2 potassium channel opener activity. Bioorg. Med. Chem. Lett., 2005, 15, 363-366.
191. Wu, Y.J.; He, H.; Sun, L.Q.; L'Heureux, A.; Chen, J.; Dextraze, P.; Starrett, J.E., Jr.; Boissard, C.G.; Gribkoff, V.K.; Natale, J.; Dworetzky, S.I. Synthesis and structure-activity relationship of acrylamides as KCNQ2 potassium channel openers. J. Med. Chem., 2004, 47, 2887-2896.
192. Dupuis, D.S.; Schroder, R.L.; Jespersen, T.; Christensen, J.K.; Christophersen, P.; Jensen, B.S.; Olesen, S.P. Activation of KCNQ5 channels stably expressed in HEK293 cells by BMS-204352. Eur. J. Pharmacol., 2002, 437, 129-137.
193. Xiong, Q.; Sun, H.; Li, M. Zinc pyrithione-mediated activation of voltage-gated KCNQ potassium channels rescues epileptogenic mutants. Nat. Chem. Biol., 2007, 3, 287-296.
194. + channels as a mechanism of cytoprotective neuronal silencing. EMBO J., 2006, 25, 4996-5004.
195. Gao, Z.; Zhang, T.; Wu, M.; Xiong, Q.; Sun, H.; Zhang, Y.; Zu, L.; Wang, W.; Li, M. Isoform-specific prolongation of Kv7 (KCNQ) potassium channel opening mediated by new molecular determinants for drug-channel interactions. J. Biol. Chem., 2010, 285, 28322-28332.
196. Wuttke, T.V.; Seebohm, G.; Bail, S.; Maljevic, S.; Lerche, H. The new anticonvulsant retigabine favors voltage-dependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gate. Mol. Pharmacol., 2005, 67, 1009-1017.
197. + channel sensitivity to the anticonvulsant retigabine. J. Neurosci., 2005, 25, 5051-5060.
198. Tatulian, L.; Brown, D.A. Effect of the KCNQ potassium channel opener retigabine on single KCNQ2/3 channels expressed in CHO cells. J. Physiol., 2003, 549, 57-63.
199. Xu, W.; Wu, Y.; Bi, Y.; Tan, L.; Gan, Y.; Wang, K. Activation of voltage-gated KCNQ/Kv7 channels by anticonvulsant retigabine attenuates mechanical allodynia of inflammatory temporomandibular joint in rats. Mol. Pain, 2010, 6, 49.
200. Wu, Y.J.; Boissard, C.G.; Chen, J.; Fitzpatrick, W.; Gao, Q.; Gribkoff, V.K.; Harden, D.G.; He, H.; Knox, R.J.; Natale, J.; Pieschl, R.L.; Starrett, J.E., Jr.; Sun, L.Q.; Thompson, M.; Weaver, D.; Wu, D.; Dworetzky, S.I. (S)-N-[1-(4-cyclopropylmethyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-ethyl]-3-(2-f luoro-phenyl)-acrylamide is a potent and efficacious KCNQ2 opener which inhibits induced hyperexcitability of rat hippocampal neurons. Bioorg. Med. Chem. Lett., 2004, 14, 1991-1995.
201. Wu, Y.J.; Sun, L.Q.; He, H.; Chen, J.; Starrett, J.E., Jr.; Dextraze, P.; Daris, J.P.; Boissard, C.G.; Pieschl, R.L.; Gribkoff, V.K.; Natale, J.; Knox, R.J.; Harden, D.G.; Thompson, M.W.; Fitzpatrick, W.; Weaver, D.; Wu, D.; Gao, Q.; Dworetzky, S.I. Synthesis and KCNQ2 opener activity of N-1-benzo[1,3]dioxol-5-yl-ethyl, N-1-(2,3-dihydro-benzofuran-5-yl)-ethyl, and N-1-(2,3-dihydro-1H-indol-5-yl)-ethyl acrylamides. Bioorg. Med. Chem. Lett., 2004, 14, 4533-4537.
202. Bentzen, B.H.; Schmitt, N.; Calloe, K.; Dalby Brown, W.; Grunnet, M.; Olesen, S.P. The acrylamide (S)-1 differentially affects Kv7 (KCNQ) potassium channels. Neuropharmacology, 2006, 51, 1068-1077.
203. Wickenden, A.D.; Krajewski, J.L.; London, B.; Wagoner, P.K.; Wilson, W.A.; Clark, S.; Roeloffs, R.; McNaughton-Smith, G.; Rigdon, G.C. N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activator. Mol. Pharmacol., 2008, 73, 977-986.
204. Otto, J.F.; Kimball, M.M.; Wilcox, K.S. Effects of the anticonvulsant retigabine on cultured cortical neurons: changes in electroresponsive properties and synaptic transmission. Mol. Pharmacol., 2002, 61, 921-927.
205. Padilla, K.; Wickenden, A.D.; Gerlach, A.C.; McCormack, K. The KCNQ2/3 selective channel opener ICA-27243 binds to a novel voltage-sensor domain site. Neurosci. Lett., 2009, 465, 138-142.
206. + channel KCNQ genes in human arteries. Br. J. Pharmacol., 2011, 162, 42-53.
207. + currents in type I hair cells and calyx afferent endings of the developing rat utricle. J. Neurosci., 2006, 26, 10253-10269.
208. + channel mutated in a form of dominant deafness, is expressed in the inner ear and the central auditory pathway. Proc. Natl. Acad. Sci. U. S. A., 2000, 97, 4333-4338.
209. Jia, C.; Qi, J.; Zhang, F.; Mi, Y.; Zhang, X.; Chen, X.; Liu, L.; Du, X.; Zhang, H. Activation of KCNQ2/3 potassium channels by novel pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives. Pharmacology, 2011, 87, 297-310.
210. Qi, J.; Zhang, F.; Mi, Y.; Fu, Y.; Xu, W.; Zhang, D.; Wu, Y.; Du, X.; Jia, Q.; Wang, K.; Zhang, H. Design, synthesis and biological activity of pyrazolo[1,5-a]pyrimidin-7(4H)-ones as novel Kv7/ KCNQ potassium channel activators. Eur. J. Med. Chem., 2011, 46, 934-943.
211. Zhang, F.; Mi, Y.; Qi, J.L.; Li, J.W.; Si, M.; Guan, B.C.; Du, X.N.; An, H.L.; Zhang, H.L. Modulation of Kv7 potassium channels by a novel opener pyrazolo[1,5-a]pyrimidin-7(4H)-one compound QO-58. Br. J. Pharmacol., 2012, 168 (4),1030-42.
212. Peretz, A.; Sheinin, A.; Yue, C.; Degani-Katzav, N.; Gibor, G.; Nachman, R.; Gopin, A.; Tam, E.; Shabat, D.; Yaari, Y.; Attali, B. Pre-and postsynaptic activation of M-channels by a novel opener dampens neuronal firing and transmitter release. J. Neurophysiol., 2007, 97, 283-295.
213. + channels with a new gating-modifier. Proc. Natl. Acad. Sci. U. S. A., 2010, 107, 15637-15642.
214. + channels reveals the mechanism of augmentation by a cysteine-modifying reagent. J. Neurosci., 2004, 24, 5079-5090.
215. + channels. Br. J. Pharmacol., 2002, 137, 1173-1186.
216. Lawson, K. Potassium Channels as Targets for the Management of Pain. Central Nervous System Agents Med. Chem., 2006, 6, 119-128.
217. Jespersen, T.; Grunnet, M.; Rasmussen, H.B.; Jorgensen, N.B.; Jensen, H.S.; Angelo, K.; Olesen, S.P.; Klaerke, D.A. The corticosteroid hormone induced factor: a new modulator of KCNQ1 channels? Biochem. Biophys. Res Commun., 2006, 341, 979-988.
218. Tulleuda, A.; Cokic, B.; Callejo, G.; Saiani, B.; Serra, J.; Gasull, X. TRESK channel contribution to nociceptive sensory neurons excitability: modulation by nerve injury. Mol. Pain, 2011, 7, 30.
219. Sarantopoulos, C.D.; McCallum, J.B.; Rigaud, M.; Fuchs, A.; Kwok, W.M.; Hogan, Q.H. Opposing effects of spinal nerve ligation on calcium-activated potassium currents in axotomized and adjacent mammalian primary afferent neurons. Brain Res., 2007, 1132, 84-99.
220. ATP channel activity in primary afferent neurons mediates hyperalgesia after axotomy. Proc. Natl. Acad. Sci. U. S. A., 2009, 106, 8725-8730.